Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.

Chen, Xian Jie Cindy; Altshuler, Diana; Spiegler, Peter; Brosnahan, Shari B

Chen, Xian Jie Cindy; Altshuler, Diana; Spiegler, Peter; Brosnahan, Shari B.

Chen XJC; New York University Langone Health, New York, NY, USA.
Altshuler D; New York University Langone Health, New York, NY, USA.
Spiegler P; New York University Long Island School of Medicine, New York, NY, USA.
Brosnahan SB; New York University Grossman School of Medicine, New York, NY, USA.

Ann Pharmacother ; 56(4): 507-508, 2022 04.

Article in English | MEDLINE | ID: covidwho-1334690

Subject(s)

COVID-19 Drug Treatment; Respiratory Insufficiency; Adrenal Cortex Hormones/adverse effects; Antibodies, Monoclonal, Humanized; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Insufficiency / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Ann Pharmacother Journal subject: Pharmacology / Drug Therapy Year: 2022 Document Type: Article Affiliation country: 10600280211036047

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google